生物醫藥技術全國重點實驗室
（香港大學）
State Key Laboratory of Pharmaceutical Biotechnology
（The University of Hong Kong)
Field of Research
Develops efficient methods to produce highly active and high-quality antigen proteins. Focuses on translating discoveries into real-world tools, enabling rapid testing for autoimmune diseases
Biography
LIU Jiaxin is currently a Research Officer specializing in recombinant protein expression. After obtaining her M.Sc. from HKUST, she joined the State Key Laboratory of Pharmaceutical Biotechnology in 2017 and has since played a key role in establishing robust expression platforms. Her work focuses on producing high-activity antigens to support research into disease mechanisms and diagnostic markers. Together with her team, she has successfully developed antigens for a range of metabolic and autoimmune diseases, as well as accompanying rapid detection products.